D
Vera Therapeutics, Inc.
VERA
$28.82
-$0.48-1.64%
D
Sell
5/14/2024Upgraded
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E+ on 5/14/2024 due to a large increase in the total return index, solvency index and growth index. The quick ratio increased from 7.21 to 27.87, debt to equity declined from 0.51 to 0.15, and earnings per share increased from -$0.5771 to -$0.5568.
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E+ on 5/14/2024 due to a large increase in the total return index, solvency index and growth index. The quick ratio increased from 7.21 to 27.87, debt to equity declined from 0.51 to 0.15, and earnings per share increased from -$0.5771 to -$0.5568.
E
Sell
5/9/2024Downgrade
Vera Therapeutics, Inc. (VERA) was downgraded to E+ from D- on 5/9/2024 due to a large decline in the solvency index and valuation index. Debt to equity increased from 0.22 to 0.51.
Vera Therapeutics, Inc. (VERA) was downgraded to E+ from D- on 5/9/2024 due to a large decline in the solvency index and valuation index. Debt to equity increased from 0.22 to 0.51.
D
Sell
7/27/2023Upgraded
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E+ on 7/27/2023 due to an increase in the volatility index and total return index.
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E+ on 7/27/2023 due to an increase in the volatility index and total return index.
E
Sell
6/30/2023Downgrade
Vera Therapeutics, Inc. (VERA) was downgraded to E+ from D- on 6/30/2023 due to a decline in the valuation index and volatility index.
Vera Therapeutics, Inc. (VERA) was downgraded to E+ from D- on 6/30/2023 due to a decline in the valuation index and volatility index.
D
Sell
6/15/2023Upgraded
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E+ on 6/15/2023 due to an increase in the solvency index, volatility index and valuation index. The quick ratio increased from 4.48 to 8.38, and debt to equity declined from 0.36 to 0.17.
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E+ on 6/15/2023 due to an increase in the solvency index, volatility index and valuation index. The quick ratio increased from 4.48 to 8.38, and debt to equity declined from 0.36 to 0.17.
E
Sell
5/15/2023Downgrade
Vera Therapeutics, Inc. (VERA) was downgraded to E+ from D- on 5/15/2023 due to a decline in the volatility index and valuation index.
Vera Therapeutics, Inc. (VERA) was downgraded to E+ from D- on 5/15/2023 due to a decline in the volatility index and valuation index.
D
Sell
4/28/2023Upgraded
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E+ on 4/28/2023 due to an increase in the volatility index and valuation index.
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E+ on 4/28/2023 due to an increase in the volatility index and valuation index.
E
Sell
3/31/2023Downgrade
Vera Therapeutics, Inc. (VERA) was downgraded to E+ from D- on 3/31/2023 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.07 to 0.36, and the quick ratio declined from 7.19 to 4.48.
Vera Therapeutics, Inc. (VERA) was downgraded to E+ from D- on 3/31/2023 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.07 to 0.36, and the quick ratio declined from 7.19 to 4.48.
D
Sell
3/14/2023Downgrade
Vera Therapeutics, Inc. (VERA) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
Vera Therapeutics, Inc. (VERA) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
Vera Therapeutics, Inc. (VERA) was upgraded to D from D- on 02/23/2023.
Vera Therapeutics, Inc. (VERA) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Vera Therapeutics, Inc. (VERA) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the total return index, growth index and volatility index. EBIT declined 67.66% from -$15.06M to -$25.24M, and earnings per share declined from -$0.5485 to -$0.9068.
Vera Therapeutics, Inc. (VERA) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the total return index, growth index and volatility index. EBIT declined 67.66% from -$15.06M to -$25.24M, and earnings per share declined from -$0.5485 to -$0.9068.
D
Sell
6/1/2022Upgraded
Vera Therapeutics, Inc. (VERA) was upgraded to D from D- on 6/1/2022 due to a large increase in the growth index, solvency index and valuation index. Debt to equity declined from 0.07 to 0.06, and earnings per share increased from -$0.7918 to -$0.7052.
Vera Therapeutics, Inc. (VERA) was upgraded to D from D- on 6/1/2022 due to a large increase in the growth index, solvency index and valuation index. Debt to equity declined from 0.07 to 0.06, and earnings per share increased from -$0.7918 to -$0.7052.
D
Sell
2/1/2022Upgraded
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E on 2/1/2022 due to an increase in the valuation index.
Vera Therapeutics, Inc. (VERA) was upgraded to D- from E on 2/1/2022 due to an increase in the valuation index.
E
Sell
11/15/2021Downgrade
Vera Therapeutics, Inc. (VERA) was downgraded to E from E+ on 11/15/2021 due to a decline in the efficiency index, valuation index and solvency index. Net income declined 121.44% from -$3.44M to -$7.61M, the quick ratio declined from 24.32 to 21.34, and total capital declined 7.25% from $92.16M to $85.48M.
Vera Therapeutics, Inc. (VERA) was downgraded to E from E+ on 11/15/2021 due to a decline in the efficiency index, valuation index and solvency index. Net income declined 121.44% from -$3.44M to -$7.61M, the quick ratio declined from 24.32 to 21.34, and total capital declined 7.25% from $92.16M to $85.48M.
E
Sell
11/3/2021Upgraded
Vera Therapeutics, Inc. (VERA) was upgraded to E+ from E on 11/3/2021 due to a noticeable increase in the total return index.
Vera Therapeutics, Inc. (VERA) was upgraded to E+ from E on 11/3/2021 due to a noticeable increase in the total return index.
E
Sell
10/7/2021Upgraded
Vera Therapeutics, Inc. (VERA) was upgraded to E from E- on 10/7/2021 due to an increase in the valuation index and total return index.
Vera Therapeutics, Inc. (VERA) was upgraded to E from E- on 10/7/2021 due to an increase in the valuation index and total return index.
E
Sell
9/22/2021Downgrade
Vera Therapeutics, Inc. (VERA) was downgraded to E- from E on 9/22/2021 due to a decline in the volatility index and valuation index.
Vera Therapeutics, Inc. (VERA) was downgraded to E- from E on 9/22/2021 due to a decline in the volatility index and valuation index.
E
Sell
8/20/2021None
Vera Therapeutics, Inc. (VERA) was downgraded to E from U on 08/20/2021.
Vera Therapeutics, Inc. (VERA) was downgraded to E from U on 08/20/2021.
NASDAQ
03/07/2025 4:00PM Eastern
Quotes delayed
